Using molecular-mimicry-inducing pathways of pathogens as novel drug targets

Area of Science:

• Microbiology
• Immunology
• Drug Discovery

Background:

• Microbial pathogens can induce autoimmune diseases via molecular mimicry.
• The role of autoimmunity in microbial pathogenesis requires critical evaluation.
• Evidence suggests autoimmunity is integral to tuberculosis pathology.

Purpose of the Study:

• To propose novel drug targets based on pathogen molecular mimicry.
• To outline a method for identifying these targets using Mycobacterium tuberculosis.
• To enable drug repurposing and novel therapeutic discovery for bacterial infections.

Main Methods:

• Review of clinical and experimental data on microbial-induced autoimmunity.
• Identification of molecular mimicry-inducing proteins in Mycobacterium tuberculosis.
• Proposal of a systematic approach for drug target identification.

Main Results:

• Autoimmunity is a fundamental aspect of Mycobacterium tuberculosis pathogenesis.
• Molecular mimicry-inducing proteins represent viable drug targets.
• The proposed methodology is applicable to other pathogenic bacteria.

Conclusions:

• Targeting pathogen molecular mimicry offers a promising strategy for treating autoimmune diseases.
• Novel therapeutics can be developed by focusing on these mimicry mechanisms.
• Drug repurposing is a viable approach to combat bacterial infections causing autoimmunity.